INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "CDK4 INHIBITORS AND COMBINATIONS WITH CDK2 INHIBITORS OR FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Oct. 4 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/053062) for "CDK4 INHIBITORS AND COMBINATIONS WITH CDK2 INHIBITORS OR FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER" on Mar 24, 2025. With publication no. WO/2025/202854, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERS, Lars (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), PASCUAL, Bernadette (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), YU...